Cargando…
P1130: ACALABRUTINIB IN TREATMENT-NAIVE OR RELAPSED/REFRACTORY WALDENSTRÖM MACROGLOBULINEMIA: 5-YEAR FOLLOW-UP OF A PHASE 2, SINGLE-ARM STUDY
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431287/ http://dx.doi.org/10.1097/01.HS9.0000847388.33116.c7 |
| _version_ | 1784780012853919744 |
|---|---|
| author | Owen, R. McCarthy, H. Rule, S. D’Sa, S. Thomas, S. Tournilhac, O. Forconi, F. José Kersten, M. Luigi Zinzani, P. Iyengar, S. Kothari, J. Minnema, M. Kastritis, E. Cheson, B. Walter, H. Greewald, D. Calvo, R. Wun, C.-C. Furman, R. |
| author_facet | Owen, R. McCarthy, H. Rule, S. D’Sa, S. Thomas, S. Tournilhac, O. Forconi, F. José Kersten, M. Luigi Zinzani, P. Iyengar, S. Kothari, J. Minnema, M. Kastritis, E. Cheson, B. Walter, H. Greewald, D. Calvo, R. Wun, C.-C. Furman, R. |
| author_sort | Owen, R. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9431287 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94312872022-08-31 P1130: ACALABRUTINIB IN TREATMENT-NAIVE OR RELAPSED/REFRACTORY WALDENSTRÖM MACROGLOBULINEMIA: 5-YEAR FOLLOW-UP OF A PHASE 2, SINGLE-ARM STUDY Owen, R. McCarthy, H. Rule, S. D’Sa, S. Thomas, S. Tournilhac, O. Forconi, F. José Kersten, M. Luigi Zinzani, P. Iyengar, S. Kothari, J. Minnema, M. Kastritis, E. Cheson, B. Walter, H. Greewald, D. Calvo, R. Wun, C.-C. Furman, R. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431287/ http://dx.doi.org/10.1097/01.HS9.0000847388.33116.c7 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Owen, R. McCarthy, H. Rule, S. D’Sa, S. Thomas, S. Tournilhac, O. Forconi, F. José Kersten, M. Luigi Zinzani, P. Iyengar, S. Kothari, J. Minnema, M. Kastritis, E. Cheson, B. Walter, H. Greewald, D. Calvo, R. Wun, C.-C. Furman, R. P1130: ACALABRUTINIB IN TREATMENT-NAIVE OR RELAPSED/REFRACTORY WALDENSTRÖM MACROGLOBULINEMIA: 5-YEAR FOLLOW-UP OF A PHASE 2, SINGLE-ARM STUDY |
| title | P1130: ACALABRUTINIB IN TREATMENT-NAIVE OR RELAPSED/REFRACTORY WALDENSTRÖM MACROGLOBULINEMIA: 5-YEAR FOLLOW-UP OF A PHASE 2, SINGLE-ARM STUDY |
| title_full | P1130: ACALABRUTINIB IN TREATMENT-NAIVE OR RELAPSED/REFRACTORY WALDENSTRÖM MACROGLOBULINEMIA: 5-YEAR FOLLOW-UP OF A PHASE 2, SINGLE-ARM STUDY |
| title_fullStr | P1130: ACALABRUTINIB IN TREATMENT-NAIVE OR RELAPSED/REFRACTORY WALDENSTRÖM MACROGLOBULINEMIA: 5-YEAR FOLLOW-UP OF A PHASE 2, SINGLE-ARM STUDY |
| title_full_unstemmed | P1130: ACALABRUTINIB IN TREATMENT-NAIVE OR RELAPSED/REFRACTORY WALDENSTRÖM MACROGLOBULINEMIA: 5-YEAR FOLLOW-UP OF A PHASE 2, SINGLE-ARM STUDY |
| title_short | P1130: ACALABRUTINIB IN TREATMENT-NAIVE OR RELAPSED/REFRACTORY WALDENSTRÖM MACROGLOBULINEMIA: 5-YEAR FOLLOW-UP OF A PHASE 2, SINGLE-ARM STUDY |
| title_sort | p1130: acalabrutinib in treatment-naive or relapsed/refractory waldenström macroglobulinemia: 5-year follow-up of a phase 2, single-arm study |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431287/ http://dx.doi.org/10.1097/01.HS9.0000847388.33116.c7 |
| work_keys_str_mv | AT owenr p1130acalabrutinibintreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemia5yearfollowupofaphase2singlearmstudy AT mccarthyh p1130acalabrutinibintreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemia5yearfollowupofaphase2singlearmstudy AT rules p1130acalabrutinibintreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemia5yearfollowupofaphase2singlearmstudy AT dsas p1130acalabrutinibintreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemia5yearfollowupofaphase2singlearmstudy AT thomass p1130acalabrutinibintreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemia5yearfollowupofaphase2singlearmstudy AT tournilhaco p1130acalabrutinibintreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemia5yearfollowupofaphase2singlearmstudy AT forconif p1130acalabrutinibintreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemia5yearfollowupofaphase2singlearmstudy AT josekerstenm p1130acalabrutinibintreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemia5yearfollowupofaphase2singlearmstudy AT luigizinzanip p1130acalabrutinibintreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemia5yearfollowupofaphase2singlearmstudy AT iyengars p1130acalabrutinibintreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemia5yearfollowupofaphase2singlearmstudy AT kotharij p1130acalabrutinibintreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemia5yearfollowupofaphase2singlearmstudy AT minnemam p1130acalabrutinibintreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemia5yearfollowupofaphase2singlearmstudy AT kastritise p1130acalabrutinibintreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemia5yearfollowupofaphase2singlearmstudy AT chesonb p1130acalabrutinibintreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemia5yearfollowupofaphase2singlearmstudy AT walterh p1130acalabrutinibintreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemia5yearfollowupofaphase2singlearmstudy AT greewaldd p1130acalabrutinibintreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemia5yearfollowupofaphase2singlearmstudy AT calvor p1130acalabrutinibintreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemia5yearfollowupofaphase2singlearmstudy AT wuncc p1130acalabrutinibintreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemia5yearfollowupofaphase2singlearmstudy AT furmanr p1130acalabrutinibintreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemia5yearfollowupofaphase2singlearmstudy |